Mandatory Training For Opioid Prescribers Remains Stuck On Drawing Board

The Obama administration unveiled no plans to make prescriber education on patient selection and appropriate use of long-acting/extended-release opioids mandatory when FDA announced a voluntary process as part of its risk management plan for the drugs July 9.

The safety program consists of similar Risk Evaluation and Mitigation Strategies for 12 brand and 23 generic drugs and a single system, supported by the 19 sponsors of the products, to finance the voluntary training program through continuing medical education courses and a joint assessment of whether their REMS are deterring abuse and misuse of the narcotics, the goal of FDA’s “class-wide” REMS Also see "